Lazard Reports Mixed 2025 Results with Revenue & AUM Growth, Continues Share Buybacks
Summary
Lazard's 2025 annual report shows revenue and AUM growth, but a GAAP net income decline due to a prior year's non-recurring gain. The company maintained strong operational performance and continued significant share repurchases.
Key Events
-
Full-Year 2025 Financials
Net revenue increased 1.5% to $3.10 billion, and adjusted net revenue rose 4.8% to $3.03 billion. However, GAAP net income attributable to Lazard decreased 15.4% to $236.8 million, and diluted EPS fell 19.0% to $2.17, largely due to a non-recurring gain in 2024.
-
Asset Growth
Assets Under Management (AUM) grew 12.4% to $254 billion as of December 31, 2025, driven by market and foreign exchange appreciation.
-
Shareholder Returns
The company repurchased $91 million of common stock in 2025, with $109 million remaining under its authorization, aimed at offsetting dilution from incentive compensation.
-
Executive Appointments Confirmed
The report confirms Tracy Farr's appointment as Chief Financial Officer effective February 1, 2026, and Christopher Hogbin as CEO of Asset Management in December 2025.
Analysis
Lazard's 2025 annual report reveals a mixed financial picture with increased net revenue and assets under management (AUM), alongside a decrease in GAAP net income and EPS. The decline in GAAP net income is primarily attributed to a non-recurring gain from an office building sale in 2024. Operationally, adjusted net revenue and adjusted operating income showed positive growth. The company continued its significant share repurchase program, buying back $91 million in stock during 2025, with $109 million remaining, demonstrating a commitment to shareholder returns and offsetting dilution. The report also highlights robust internal controls and comprehensive cybersecurity risk management, providing a solid governance foundation.
At the time of this filing, LAZ was trading at $49.32 on NYSE in the Finance sector, with a market capitalization of approximately $4.7B. The 52-week trading range was $31.97 to $58.75. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.